• Lisbon International Symposium
  & 3rd Ethics Workshop
• Theatre premiere
  Staminalia: a Dream and a Trial
• partner-organised events
• PREVIOUS EVENTS ORGANISED BY ESTOOLS ⬇
• Sofia Stem Cells Symposium - Софийски Отворен Симпозиум за Стволовите Клетки
• Third Annual Meeting & Open Symposium - Rome May 2009
• Winter School - Lapland January 2009
• Second Ethics Workshop - Lund October 2008
• Second Annual Meeting - Budapest June 2008
• Media Training Workshop - Turku April 2008
• Scientific Communication Workshop - Edinburgh October 2007
• Recombineering workshop - Dresden September 2007
• First Annual Meeting - Brno May 2007
• FACS workshop - Sheffield May 2007
• First Ethics Public Workshop - Berlin April 2007
• Summer School - Sheffield August/September 2006

 

19-20 April: Ethical Aspects of Stem Cell Research in Europe

Workshop 3: Ethical Aspects of Stem Cell Research in Europe
19-20 April 2007, Berlin

Berlin, Germany

Workshop 3: Ethical Aspects of Stem Cell Research in Europe
19-20 April 2007, Berlin

The workshop was organised by two EU-funded Integrated Projects, EuroStemCell (co-ordinated by Austin Smith, Cambridge) and ESTOOLS (co-ordinated by Peter Andrews, Sheffield).

Download the final report from the workshop. 

Programme:
The meeting focused on ethical aspects of possible clinical application of stem cell research and derivation of human embryonic stem cell lines and their alternatives. The two main themes were:
(1) The roadmap to the clinic
(2) Derivation of human embryonic stem cell lines.

Download the FINAL programme

Venue
Maritim proArte Hotel, Friedrichstrasse 151, Berlin
map
website (link opens in new window)
 

Introduction
How should we develop, interpret and select criteria for ethically acceptable clinical applications of stem cell research?
What are the ethical and regulatory issues relevant to the derivation and use of human embryonic stem cells?

Workshop themes
(1) "The roadmap to the clinic" which discussed

• Regulatory Background
• Scientific State of the Art
• Intellectual Property Protection
• Commercialization

(2) "Derivation of human embryonic stem cell lines" which discussed

• Scientific State of the Art
• Ethical and Societal Aspects
• Council of Europe Perspectives

Countries represented

Austria Belgium Czech Republic Denmark

Finland France Germany Italy

Latvia Portugal Saudi Arabia Spain

Sweden Switzerland United Kingdom USA

Participants
Over 100 participants attended this workshop. Like the invited speakers, they
represented the spectrum of communities interested in or concerned by the ethical societal and regulatory issues raised by the clinical application of stem cell research, and in particular the derivation and use of human embryonic stem cells. Participants included scientists working in the area of stem cell research, lawyers, ethicists, philosophers, as well as the representatives of patients’ organizations and of the European Commission.